[Human papillomavirus vaccination for men who have sex with men in China: demand and suggestions].
Zhonghua Liu Xing Bing Xue Za Zhi
; 44(8): 1321-1326, 2023 Aug 10.
Article
in Zh
| MEDLINE
| ID: mdl-37661628
ABSTRACT
MSM are a high-risk population for HPV infection and related diseases. MSM can be effectively protected by quadrivalent and nine-valent HPV vaccines. This paper outlines the significance of providing HPV vaccination to MSM, summarizes the basis of HPV vaccination in MSM, and puts forward the following recommendations. First, China should expedite the development and approval of the HPV vaccine for male use. Second, HIV-positive MSM should vaccinate against HPV as soon as possible. Third, prioritize HPV vaccination for MSM individuals aged 26 or less. Fourth, for MSM aged over 26, catch-up vaccination or opportunistic vaccination should be provided when HPV vaccine resources are sufficient. Implementing this vaccination strategy can provide protection for the MSM and control the spread of sexually transmitted diseases.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Papillomavirus Infections
/
Papillomavirus Vaccines
/
Sexual and Gender Minorities
Limits:
Humans
/
Male
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Liu Xing Bing Xue Za Zhi
Year:
2023
Document type:
Article
Affiliation country:
China